| Name | Title | Contact Details |
|---|
Health Sun is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NLP Logix is an advanced analytics and machine learning data product and services company, which has grown from a vision in 2011 to one of the fastest growing teams of deep learning practitioners. NLP Logix is an experienced team of data scientists who are capable of taking large and disparate data sources and returning actionable and valuable information in a fraction of the time compared to traditional techniques. The company was started by three professionals who worked together at a medical services company developing and applying predictive models and advanced analytics into its workflows. When the founders started NLP Logix, they began competing in international data science contests hosted by Kaggle.com…and started winning. The founders knew that developing algorithms through machine learning was only one piece of the solution, so they began to focus on the practical application of integrating the learned models into a customers` workflow to deliver the most value at the point where decisions were being made. That business model lives today.
Dedicated Clinical Research II-IV is a Litchfield Park, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sunrise Senior Living is a company that provides personalized senior care and living options including assisted living, independent living, and memory care.
lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.